PORTA, CAMILLO
PORTA, CAMILLO
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells
2015-01-01 Tancredi, Richard; Fotia, Vittoria; Moccia, Francesco; Rosti, V.; Porta, C.; DELLA PORTA, MATTEO GIOVANNI; Beltrame, Luca; Da Prada, G. A.; Zambelli, A.; Riccardi, Alberto
5-Fluorouracil combined with the pure L-stereoisomer of leukovorin calcium to treat advanced colon-cancer patients - a phase-ii study
1995-01-01 Porta, C; Moroni, M; Nastasi, G
5-methyltetrahydrofolate or 5-formyltetrahydrofolic acid to modulate 5-fluorouracil's cytotoxic activity in vivo. A phase II study in patients with advanced colon cancer
1996-01-01 Porta, C; Moroni, M; Epis, O; Nastasi, G
Acute Kidney Injury in Cancer Patients
2018-01-01 Gallieni, Maurizio; Cosmai, Laura; Porta, Camillo
Acute promyelocytic leukaemia (APL): chemotherapy or bone marrow transplantation?
1989-01-01 Bobbio Pallavicini, E; Porta, C; Anselmetti, L; Viarengo, G L; Nastasi, G; Notario, A
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials
2016-01-01 Massari, F.; Modena, A.; Ciccarese, C.; Pilotto, S.; Maines, F.; Bracarda, S.; Sperduti, I.; Giannarelli, D.; Carlini, PIETRO MARIO; Santini, D.; Tortora, G.; Porta, C.; Bria, E.
Adjuvant therapy in renal cell carcinoma
2017-01-01 Massari, F.; Di Nunno, V.; Ciccarese, C.; Graham, J.; Porta, C.; Comito, F.; Cubelli, M.; Iacovelli, R.; Heng, D. Y. C.
The adjuvant treatment of kidney cancer: a multidisciplinary outlook
2019-01-01 Porta, C.; Cosmai, L.; Leibovich, B. C.; Powles, T.; Gallieni, M.; Bex, A.
Algorithms in the first-line treatment of metastatic clear cell renal cell carcinoma—analysis using diagnostic nodes
2015-01-01 Rothermundt, C.; Bailey, A.; Cerbone, L.; Eisen, T.; Escudier, B.; Gillessen, S.; Grunwald, V.; Larkin, J.; Mcdermott, D.; Oldenburg, J.; Porta, C.; Rini, B.; Schmidinger, M.; Sternberg, C.; Putora, P. M.
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis
1994-01-01 Montecucco, Carlomaurizio; Caporali, Roberto; Rossi, S.; Porta, C.
Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis
1994-01-01 Porta, C; Moroni, M; Nastasi, G
Alterata espressione dei canali del Ca2+ in cellule progenitrici endoteliali di pazienti affetti da carcinoma cellulare renale, mielofibrosi idiopatica e tumore della mammella
2012-01-01 Bottino, Cinzia; Rosti, Vittorio; Bonetti, Elisa; DELLA PORTA, MATTEO GIOVANNI; Pedrazzoli, Paolo; Porta, Camillo; Tanzi, Francesco; Moccia, Francesco; Laforenza, Umberto
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas
1998-01-01 Ghigna, C; Moroni, M; Porta, C; Riva, S; Biamonti, G
Amifostine (WR-2721, Ethyol(TM)) can protect human endothelial but not tumor cells from cisplatin-induced cytotoxicity
1997-01-01 Moroni, M; Porta, C; Finotti, N; Regazzibonora, M; Bertorelli, Laura; Borasio, E; Greco, R; Marzatico, F
Analysis of TERRA expression in Head and Neck Tumors.
2012-01-01 Vitelli, V; Nergadze, Solomon; Khoriauli, Lela; Pellanda, P; Porta, C; Giulotto, Elena
Analysis of TERRA expression in Head and Neck Tumors.
2012-01-01 Vitelli, V; Nergadze, Solomon; Khoriauli, Lela; Pellanda, P; Porta, C; Giulotto, Elena
Androgen receptor (AR) splice variant 7 and full-length AR expression is associated with clinical outcome: a translational study in patients with castrate-resistant prostate cancer
2019-01-01 Del Re, M.; Crucitta, S.; Sbrana, A.; Rofi, E.; Paolieri, F.; Gianfilippo, G.; Galli, L.; Falcone, A.; Morganti, R.; Porta, C.; Efstathiou, E.; van Schaik, R.; Jenster, G.; Danesi, R.
Angiogenic and immunological pathways in metastatic renal cell carcinoma: A counteracting paradigm or two faces of the same medal? The GIANUS Review
2019-01-01 Bracarda, S.; Porta, C.; Sabbatini, R.; Rivoltini, L.
Anti-HCV antibodies and hepatocellular carcinoma. Relationship in a medium-risk population
1992-01-01 Porta, C; Moroni, M; Nastasi, G; Ricci, G; Casagranda, I
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP
1997-01-01 Bobbio-Pallavicini, E; Gugliotta, L; Centurioni, R; Porta, C; Vianelli, N; Billio, A; Tacconi, F; Ascari, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells | 1-gen-2015 | Tancredi, Richard; Fotia, Vittoria; Moccia, Francesco; Rosti, V.; Porta, C.; DELLA PORTA, MATTEO GIOVANNI; Beltrame, Luca; Da Prada, G. A.; Zambelli, A.; Riccardi, Alberto | |
| 5-Fluorouracil combined with the pure L-stereoisomer of leukovorin calcium to treat advanced colon-cancer patients - a phase-ii study | 1-gen-1995 | Porta, C; Moroni, M; Nastasi, G | |
| 5-methyltetrahydrofolate or 5-formyltetrahydrofolic acid to modulate 5-fluorouracil's cytotoxic activity in vivo. A phase II study in patients with advanced colon cancer | 1-gen-1996 | Porta, C; Moroni, M; Epis, O; Nastasi, G | |
| Acute Kidney Injury in Cancer Patients | 1-gen-2018 | Gallieni, Maurizio; Cosmai, Laura; Porta, Camillo | |
| Acute promyelocytic leukaemia (APL): chemotherapy or bone marrow transplantation? | 1-gen-1989 | Bobbio Pallavicini, E; Porta, C; Anselmetti, L; Viarengo, G L; Nastasi, G; Notario, A | |
| Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials | 1-gen-2016 | Massari, F.; Modena, A.; Ciccarese, C.; Pilotto, S.; Maines, F.; Bracarda, S.; Sperduti, I.; Giannarelli, D.; Carlini, PIETRO MARIO; Santini, D.; Tortora, G.; Porta, C.; Bria, E. | |
| Adjuvant therapy in renal cell carcinoma | 1-gen-2017 | Massari, F.; Di Nunno, V.; Ciccarese, C.; Graham, J.; Porta, C.; Comito, F.; Cubelli, M.; Iacovelli, R.; Heng, D. Y. C. | |
| The adjuvant treatment of kidney cancer: a multidisciplinary outlook | 1-gen-2019 | Porta, C.; Cosmai, L.; Leibovich, B. C.; Powles, T.; Gallieni, M.; Bex, A. | |
| Algorithms in the first-line treatment of metastatic clear cell renal cell carcinoma—analysis using diagnostic nodes | 1-gen-2015 | Rothermundt, C.; Bailey, A.; Cerbone, L.; Eisen, T.; Escudier, B.; Gillessen, S.; Grunwald, V.; Larkin, J.; Mcdermott, D.; Oldenburg, J.; Porta, C.; Rini, B.; Schmidinger, M.; Sternberg, C.; Putora, P. M. | |
| Allopurinol Mouthwashes In Methotrexate-induced Stomatitis | 1-gen-1994 | Montecucco, Carlomaurizio; Caporali, Roberto; Rossi, S.; Porta, C. | |
| Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis | 1-gen-1994 | Porta, C; Moroni, M; Nastasi, G | |
| Alterata espressione dei canali del Ca2+ in cellule progenitrici endoteliali di pazienti affetti da carcinoma cellulare renale, mielofibrosi idiopatica e tumore della mammella | 1-gen-2012 | Bottino, Cinzia; Rosti, Vittorio; Bonetti, Elisa; DELLA PORTA, MATTEO GIOVANNI; Pedrazzoli, Paolo; Porta, Camillo; Tanzi, Francesco; Moccia, Francesco; Laforenza, Umberto | |
| Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas | 1-gen-1998 | Ghigna, C; Moroni, M; Porta, C; Riva, S; Biamonti, G | |
| Amifostine (WR-2721, Ethyol(TM)) can protect human endothelial but not tumor cells from cisplatin-induced cytotoxicity | 1-gen-1997 | Moroni, M; Porta, C; Finotti, N; Regazzibonora, M; Bertorelli, Laura; Borasio, E; Greco, R; Marzatico, F | |
| Analysis of TERRA expression in Head and Neck Tumors. | 1-gen-2012 | Vitelli, V; Nergadze, Solomon; Khoriauli, Lela; Pellanda, P; Porta, C; Giulotto, Elena | |
| Analysis of TERRA expression in Head and Neck Tumors. | 1-gen-2012 | Vitelli, V; Nergadze, Solomon; Khoriauli, Lela; Pellanda, P; Porta, C; Giulotto, Elena | |
| Androgen receptor (AR) splice variant 7 and full-length AR expression is associated with clinical outcome: a translational study in patients with castrate-resistant prostate cancer | 1-gen-2019 | Del Re, M.; Crucitta, S.; Sbrana, A.; Rofi, E.; Paolieri, F.; Gianfilippo, G.; Galli, L.; Falcone, A.; Morganti, R.; Porta, C.; Efstathiou, E.; van Schaik, R.; Jenster, G.; Danesi, R. | |
| Angiogenic and immunological pathways in metastatic renal cell carcinoma: A counteracting paradigm or two faces of the same medal? The GIANUS Review | 1-gen-2019 | Bracarda, S.; Porta, C.; Sabbatini, R.; Rivoltini, L. | |
| Anti-HCV antibodies and hepatocellular carcinoma. Relationship in a medium-risk population | 1-gen-1992 | Porta, C; Moroni, M; Nastasi, G; Ricci, G; Casagranda, I | |
| Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP | 1-gen-1997 | Bobbio-Pallavicini, E; Gugliotta, L; Centurioni, R; Porta, C; Vianelli, N; Billio, A; Tacconi, F; Ascari, E |